12:00 AM
 | 
Mar 04, 2013
 |  BC Week In Review  |  Company News  |  Deals

Devgen, Syngenta deal

Syngenta said that as of Feb. 26, 98.32% of agbio company Devgen shares had been tendered. Syngenta said following a "squeeze-out," the results of which will be...

Read the full 113 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >